Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment (Q37755075)

22 August 2017

Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment (English)

1 reference

mild cognitive impairment

22 August 2017

0 references

0 references

1 reference

Hyman M Schipper

1

1 reference

22 August 2017

1 October 2007

1 reference

22 August 2017

Biomarkers in Medicine

1 reference

22 August 2017

1

1 reference

22 August 2017

3

1 reference

22 August 2017

375-385

1 reference

The molecular pathology of Alzheimer's disease

22 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Imaging biomarkers and their role in dementia clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Heme oxygenase expression in human central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Bilirubin is an antioxidant of possible physiological importance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Brain iron deposition and the free radical-mitochondrial theory of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Possible assessment for antioxidant capacity in Alzheimer's disease by measuring lymphocyte heme oxygenase-1 expression with real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Transcriptional profiling of Alzheimer blood mononuclear cells by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Oxidative damage to DNA in lymphocytes from AD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Dexamethasone suppression test and serum prolactin in dementia disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Serum inflammatory proteins and cognitive decline in older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.3.375

21 January 2018

Identifiers

DOI

10.2217/17520363.1.3.375

1 reference

release_e2iy7y22wbap3ko2ttavcyqx54

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e2iy7y22wbap3ko2ttavcyqx54

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

20477381

1 reference

PubMed ID

20477381